跳至主要内容
临床试验/CTRI/2025/11/097626
CTRI/2025/11/097626尚未招募2 期

Clinical Evaluation of Varuni Tailam with DashmoolKwath and Varuni Tailam Nasya in the Management of kamanvata with special reference to Parkinsons Disease

Dr Sanandan Thapliyal1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement in Tremors, Rigidity and Bradykinesia

研究概览

简要总结

This study is a randomized, double blind, parallel group trial to evaluate clinical efficacy of Varuni Tailam with Dashmool Kwath and Varuni tailam nasya in the the patients of Kampvata with special reference to Parkinson’s disease. It will have two groups (30 patients in each group) with Group 1 – Varuni Tailam 10 ml with Dashmool Kwath 20ml and Varuni Tailam Nasya (2drops/nostril), Group 2 – Tablet Ldopa 100mg daily, duration will be 8 weeks. Primary outcome being improvement in Unified Parkinson’s Disease Rating Scale (UPDRS) and secondary outcome - Improvement in Ayurveda Symptoms grading of (*Kampa /*Tremor, *Stambha /*Rigidity and Asamyakgati /Bradykinesia) as per WHO scoring of Ayurveda Symptoms, IPGTRA, Jamnagar, 2011 Guidelines.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
50.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients willing to participate and provide written consent.
  • Patients exhibiting the features of Kampavatas Age 50 to 80 yr of either sex Both freshly detected and already diagnosed cases.

排除标准

  • Patients with systemic disorders and with other complication.
  • History of repeated strokes with stepwise progression of Parkinson’s disease.
  • History of head injury.
  • History of definite encephalitis and early severe dementia.

结局指标

主要结局

Improvement in Tremors, Rigidity and Bradykinesia

时间窗: 8 Weeks

次要结局

  • Improvement in Symptoms Grading((As per WHO scoring of Ayurveda Symptoms, IPGTRA, Jamnagar, 2011 guidelines) of Kampa (Tremor), Stambha (Rigidity) and Asamyakgati (Bradykinesia/Impaired mobility).)

研究者

发起方
Dr Sanandan Thapliyal
申办方类型
Other [Ayurveda Teaching Institute]
责任方
Principal Investigator
主要研究者

Dr Sanandan Thapliyal

Shivalik Institute of Ayurveda and Research Dehradun

研究点 (1)

Loading locations...

相似试验